• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜样癌中枢纽基因的鉴定与验证:一项基于TCGA和GEO的观察性研究

Identification and validation of hub genes in uterine corpus endometrioid carcinoma: An observational study from TCGA and GEO.

作者信息

Luo Guoxian, Bo Caiying, Li Jianqi

机构信息

Department of Gynecology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

Medicine (Baltimore). 2025 May 2;104(18):e42338. doi: 10.1097/MD.0000000000042338.

DOI:10.1097/MD.0000000000042338
PMID:40324248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055170/
Abstract

Uterine corpus endometrioid carcinoma (UCEC) is a prevalent malignant tumor of the female reproductive system. Despite advancements in molecular biology and treatment strategies, the underlying molecular mechanisms of UCEC tumorigenesis remain incompletely understood. This study aimed to identify differentially expressed genes (DEGs) associated with UCEC pathogenesis, and to determine potential prognostic biomarkers and immunotherapy targets for UCEC. RNA expression datasets and clinical data from UCEC patients were collected from the UCSC Xena database and The Cancer Genome Atlas database. Principal component analysis and LIMMA methods were employed to screen 177 UCEC tissues and 24 normal endometrial tissues. Gene ontology enrichment analysis revealed that up-regulated DEGs were primarily involved in tissue development, cell cycle regulation, and epithelial development. Subsequently, weighted gene co-expression network analysis (WGCNA) identified DEGs in the blue modules that were significantly positively correlated with UCEC, while DEGs in the black modules were significantly negatively correlated with UCEC. Among the identified DEGs through WGCNA, 16 genes were selected, and further Kaplan-Meier analysis demonstrated that 5 of these genes (AURKA, CCNE1, IQGAP3, TTK, and UBE2C) were significantly negatively correlated with overall survival (OS) and considered as hub genes. The expression of these hub genes was validated using GEO datasets and immunohistochemistry (IHC) analysis from the human protein atlas. Additionally, the calculation of immune scores for immune infiltration, immune cell infiltration, and immune cell regulation across the 5 hub genes revealed potential immunotherapeutic targets and strategies. This comprehensive investigation provides insights into the molecular mechanisms underlying UCEC development, identifies 5 promising prognostic biomarkers and immunotherapy targets, and offers guidance for UCEC treatment approaches.

摘要

子宫内膜样癌(UCEC)是女性生殖系统中一种常见的恶性肿瘤。尽管分子生物学和治疗策略取得了进展,但UCEC肿瘤发生的潜在分子机制仍未完全明确。本研究旨在鉴定与UCEC发病机制相关的差异表达基因(DEGs),并确定UCEC潜在的预后生物标志物和免疫治疗靶点。从UCSC Xena数据库和癌症基因组图谱数据库收集了UCEC患者的RNA表达数据集和临床数据。采用主成分分析和LIMMA方法筛选了177例UCEC组织和24例正常子宫内膜组织。基因本体富集分析显示,上调的DEGs主要参与组织发育、细胞周期调控和上皮发育。随后,加权基因共表达网络分析(WGCNA)确定蓝色模块中的DEGs与UCEC显著正相关,而黑色模块中的DEGs与UCEC显著负相关。在通过WGCNA鉴定出的DEGs中,选择了16个基因,进一步的Kaplan-Meier分析表明,其中5个基因(AURKA、CCNE1、IQGAP3、TTK和UBE2C)与总生存期(OS)显著负相关,并被视为枢纽基因。使用GEO数据集和人类蛋白质图谱的免疫组织化学(IHC)分析验证了这些枢纽基因的表达。此外,通过计算这5个枢纽基因的免疫浸润、免疫细胞浸润和免疫细胞调节的免疫评分,揭示了潜在的免疫治疗靶点和策略。这项全面的研究深入了解了UCEC发展的分子机制,确定了5个有前景的预后生物标志物和免疫治疗靶点,并为UCEC的治疗方法提供了指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/c30767ad8c9e/medi-104-e42338-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/ea19dfdb7941/medi-104-e42338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/a8fda2410a48/medi-104-e42338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/048f90cf2d4f/medi-104-e42338-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/4924f04ed7a4/medi-104-e42338-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/7570c4df8f4f/medi-104-e42338-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/c30767ad8c9e/medi-104-e42338-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/ea19dfdb7941/medi-104-e42338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/a8fda2410a48/medi-104-e42338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/048f90cf2d4f/medi-104-e42338-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/4924f04ed7a4/medi-104-e42338-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/7570c4df8f4f/medi-104-e42338-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b7/12055170/c30767ad8c9e/medi-104-e42338-g006.jpg

相似文献

1
Identification and validation of hub genes in uterine corpus endometrioid carcinoma: An observational study from TCGA and GEO.子宫内膜样癌中枢纽基因的鉴定与验证:一项基于TCGA和GEO的观察性研究
Medicine (Baltimore). 2025 May 2;104(18):e42338. doi: 10.1097/MD.0000000000042338.
2
Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.通过综合生物信息学分析和实验验证鉴定与子宫体子宫内膜癌患者预后不良相关的枢纽基因
Front Oncol. 2021 Nov 19;11:766947. doi: 10.3389/fonc.2021.766947. eCollection 2021.
3
Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.基于加权基因共表达网络分析的与调节性 T 细胞比例相关的新型 8 基因预后标志物在子宫体子宫内膜癌中的开发与临床验证。
Front Immunol. 2021 Dec 14;12:788431. doi: 10.3389/fimmu.2021.788431. eCollection 2021.
4
Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.鉴定与子宫内膜癌进展和预后相关的新型关键基因。
Ann Transl Med. 2023 Jan 31;11(2):100. doi: 10.21037/atm-22-6461.
5
Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.基于多组学数据和免疫相关分析构建的 N-7 甲基鸟嘌呤相关 mRNA 预后模型在子宫体子宫内膜癌中的应用。
Sci Rep. 2022 Nov 5;12(1):18813. doi: 10.1038/s41598-022-22879-6.
6
[Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].[MAD2L1/CAMK2A/PTTG1基因簇失调维持子宫内膜癌的干性特征]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Oct;43(5):685-695. doi: 10.3881/j.issn.1000-503X.13271.
7
ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.ASPM、CDC20、DLGAP5、BUB1B、CDCA8 和 NCAPG 可作为子宫内膜癌的诊断和预后生物标志物。
Genet Res (Camb). 2022 Sep 17;2022:3217248. doi: 10.1155/2022/3217248. eCollection 2022.
8
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma.一种用于预测子宫体子宫内膜癌预后及免疫检查点阻断治疗反应的新型线粒体相关风险模型。
Sci Rep. 2025 Jan 9;15(1):1404. doi: 10.1038/s41598-025-85537-7.
9
Prognostic value and clinical significance of IL-33 expression in patients with uterine corpus endometrial carcinoma.白细胞介素-33表达在子宫体子宫内膜癌患者中的预后价值及临床意义
Cytokine. 2025 Jan;185:156828. doi: 10.1016/j.cyto.2024.156828. Epub 2024 Dec 9.
10
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma.铜死亡相关基因风险模型的构建预测子宫内膜癌的预后
Sci Rep. 2025 Jan 16;15(1):2210. doi: 10.1038/s41598-025-86756-8.

本文引用的文献

1
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.阿利斯替尼单药或联合氟维司群治疗内分泌耐药晚期乳腺癌患者的疗效评价:TBCRC041 期随机临床试验。
JAMA Oncol. 2023 Jun 1;9(6):815-824. doi: 10.1001/jamaoncol.2022.7949.
2
Pan-Cancer Bioinformatics Analysis of Gene UBE2C.基因UBE2C的泛癌生物信息学分析
Front Genet. 2022 Apr 27;13:893358. doi: 10.3389/fgene.2022.893358. eCollection 2022.
3
Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma.
泛素结合酶E2 C(UBE2C)可能在甲状腺癌进展过程中发挥双重作用。
Cell Death Discov. 2022 Mar 24;8(1):130. doi: 10.1038/s41420-022-00935-4.
4
Identification of co-expression hub genes for ferroptosis in kidney renal clear cell carcinoma based on weighted gene co-expression network analysis and The Cancer Genome Atlas clinical data.基于加权基因共表达网络分析和癌症基因组图谱临床数据鉴定肾透明细胞癌中铁死亡的共表达枢纽基因。
Sci Rep. 2022 Mar 21;12(1):4821. doi: 10.1038/s41598-022-08950-2.
5
Comprehensive Analyses of the Immunological and Prognostic Roles of an IQGAP3AR/let-7c-5p/IQGAP3 Axis in Different Types of Human Cancer.IQGAP3AR/let-7c-5p/IQGAP3轴在不同类型人类癌症中的免疫和预后作用的综合分析
Front Mol Biosci. 2022 Feb 22;9:763248. doi: 10.3389/fmolb.2022.763248. eCollection 2022.
6
A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma.一种与免疫浸润相关的新型九基因特征用于预测肝细胞癌的预后
Front Genet. 2021 Nov 30;12:730732. doi: 10.3389/fgene.2021.730732. eCollection 2021.
7
Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.通过综合生物信息学分析和实验验证鉴定与子宫体子宫内膜癌患者预后不良相关的枢纽基因
Front Oncol. 2021 Nov 19;11:766947. doi: 10.3389/fonc.2021.766947. eCollection 2021.
8
copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.拷贝数是卵巢和子宫内膜癌模型中对 WEE1-ATR 抑制联合治疗反应的生物标志物。
Cell Rep Med. 2021 Sep 23;2(9):100394. doi: 10.1016/j.xcrm.2021.100394. eCollection 2021 Sep 21.
9
The long-noncoding RNA SOCS2-AS1 suppresses endometrial cancer progression by regulating AURKA degradation.长非编码 RNA SOCS2-AS1 通过调控 AURKA 降解抑制子宫内膜癌进展。
Cell Death Dis. 2021 Apr 6;12(4):351. doi: 10.1038/s41419-021-03595-x.
10
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.Siglec15 塑造非炎症性肿瘤微环境,并预测膀胱癌的分子亚型。
Theranostics. 2021 Jan 1;11(7):3089-3108. doi: 10.7150/thno.53649. eCollection 2021.